ArticleFrontiers in immunology2026

Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants.

Ching-Hsuan Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.